Wedbush Maintains Outperform on Staar Surgical, Lowers Price Target to $37
STAAR Surgical Company
STAAR Surgical Company STAA | 0.00 |
Wedbush analyst Michael Piccolo maintains Staar Surgical (NASDAQ:
STAA) with a Outperform and lowers the price target from $40 to $37.